Sign up to save your podcasts
Or
Share The $100 billion opportunity: How anti-obesity drugs are reshaping healthcare and consumer behavior
Share to email
Share to Facebook
Share to X
Share to email
Share to Facebook
Share to X
Or
The $100 billion opportunity: How anti-obesity drugs are reshaping healthcare and consumer behavior
Goldman Sachs Research’s Chris Shibutani and Jason English explain the business and investor implications of the latest anti-obesity medications and their ripple effects in the healthcare industry and beyond.
Learn more about your ad choices. Visit megaphone.fm/adchoices
View all episodes
By Goldman Sachs
4.2
912912 ratings
Goldman Sachs Research’s Chris Shibutani and Jason English explain the business and investor implications of the latest anti-obesity medications and their ripple effects in the healthcare industry and beyond.
Learn more about your ad choices. Visit megaphone.fm/adchoices
More shows like Exchanges
View all
Bloomberg Surveillance
1,183 Listeners
Masters in Business
2,172 Listeners
Odd Lots
1,889 Listeners
Notes on the Week Ahead
195 Listeners
Insights Now
95 Listeners
Capital Allocators – Inside the Institutional Investment Industry
795 Listeners
Wall Street Breakfast
1,037 Listeners
Talks at GS
84 Listeners
UBS On-Air: Market Moves
182 Listeners
Making Sense
60 Listeners
Thoughts on the Market
1,297 Listeners
At Any Rate
78 Listeners
The Memo by Howard Marks
443 Listeners
Global Data Pod
29 Listeners
The Markets
76 Listeners